Developer of stem cell technologies to discover drugs that regenerate tissues of the human body. The company is developing hematopoietic stem cell therapies for thrombocytopenia, anemia, diabetes, and obesity. The proprietary technology, Combinatorial Cell Culture (CombiCult), is a bead-based high throughput screening platform used to differentiate stem cells into a variety of somatic lineages.
← All startups
Plasticell
Series ADeveloper of stem cell technologies to discover drugs that regenerate tissues of the human body. The company is developing hematopoietic stem cell therapies for thrombocytopenia, anemia, diabetes, and obesity. The proprietary technology, Combinatorial Cell Culture (CombiCult), is a bead-based high throughput screening platform used to differentiate stem cells into a variety of somatic lineages.
About
Institutional investors
Europa
Latest coverage
📰 Browse funding news — rounds, valuations, and market moves for founders.
Investor directory
🗂️ Full list of active funds — filter by stage, check size, and geography.